Taysha Gene Therapies (TSHA) Capital Expenditures (2020 - 2026)
Taysha Gene Therapies' Capital Expenditures was -$1,000 in Q2 2026, compared with $2,000 a year earlier.
Powered by 
Analysis
Taysha Gene Therapies (TSHA) Capital Expenditures (2020 - 2026) Analysis & Trends
On a trailing twelve-month basis, Taysha Gene Therapies' Capital Expenditures was $381,000 through Jun 30, 2026, down 7.7% year-over-year; for FY2025, it came in at $738,000, up 97.3% from FY2024.
- Capital Expenditures shows a five-year compound annual growth rate of 55.2% (FY2020 to FY2025).
- In earlier years, Capital Expenditures was $374,000 in FY2024 (-90.3%), $3.87 million in FY2023 (-81.2%), $20.62 million in FY2022 (+34.7%) and $15.3 million in FY2021.
- The Q2 2026 figure marks the lowest quarterly Capital Expenditures since Q4 2024.
- Compared with a year earlier, Capital Expenditures was higher in two of the last four quarters, with growth averaging 46.5%.
- The best year-over-year quarter for Capital Expenditures over five years was Q3 2025 (growth of 208.6%); the worst was Q4 2023 (a decline of 99.3%).
- Per Business Quant data, TSHA's Capital Expenditures in the three quarters before Q2 2026 was $24,000 (Q1 2026), $250,000 (Q4 2025) and $108,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 1.32 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 322.00 Mn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 893.00 Mn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | -321.00 Mn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -763.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 513.00 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 140.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 533.00 Mn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 112.20 Mn |
| 10 | Taysha Gene Therapies | 1.58 Bn | 1.58 Bn | - | -1,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -1,000.00 |
| Mar 31, 2026 | 24,000.00 |
| Dec 31, 2025 | 250,000.00 |
| Sep 30, 2025 | 108,000.00 |
| Jun 30, 2025 | 2,000.00 |
| Mar 31, 2025 | 378,000.00 |
| Dec 31, 2024 | -2,000.00 |
| Sep 30, 2024 | 35,000.00 |
| Jun 30, 2024 | 201,000.00 |
| Mar 31, 2024 | 140,000.00 |
| Dec 31, 2023 | 17,000.00 |
| Jun 30, 2023 | -48,000.00 |
| Mar 31, 2023 | 3.90 Mn |
| Dec 31, 2022 | 2.31 Mn |
| Sep 30, 2022 | 2.02 Mn |
| Jun 30, 2022 | 7.86 Mn |
| Mar 31, 2022 | 8.43 Mn |
| Dec 31, 2021 | 8.27 Mn |
| Sep 30, 2021 | 3.50 Mn |
| Jun 30, 2021 | 3.00 Mn |
API Access
Taysha Gene Therapies Capital Expenditures API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=capital-expenditures&ticker=TSHA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "capital-expenditures", "ticker": "TSHA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=capital-expenditures&ticker=TSHA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();